21 articles for K Irie
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.

Ehime University
Structural insights into mechanisms for inhibiting amyloidß42 aggregation by non-catechol-type flavonoids.

Kyoto University
Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity.

Kyoto University
Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.

Kyoto University
Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V.

Kyoto University
Generation of 'Unnatural Natural Product' library and identification of a small molecule inhibitor of XIAP.

Keio University
Role of the phenolic hydroxyl group in the biological activities of simplified analogue of aplysiatoxin with antiproliferative activity.

Kyoto University
Synthesis and characterization of the second cysteine-rich region of mouse skin PKCGh

TBA
Synthesis, conformational analysis, and biological evaluation of 1-hexylindolactam-V10 as a selective activator for novel protein kinase C isozymes.

Kyoto University
A simplified analog of debromoaplysiatoxin lacking the B-ring of spiroketal moiety retains protein kinase C-binding and antiproliferative activities.

Kagawa University
Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and eta.

Kyoto University
Synthesis and binding selectivity of 7- and 15-decylbenzolactone-V8 for the C1 domains of protein kinase C isozymes.

Kyoto University
Synthesis and biological activities of simplified aplysiatoxin analogs focused on the CH/π interaction.

Kyoto University
Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer.

Gifu Pharmaceutical University
The amide hydrogen of (-)-indolactam-V and benzolactam-V8's plays a critical role in protein kinase C binding and tumor-promoting activities.

Kyoto University
The C4 hydroxyl group of phorbol esters is not necessary for protein kinase C binding.

Kyoto University
Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes.

Stanford University
Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities.

Kyoto University
Structure-activity studies on the side chain of a simplified analog of aplysiatoxin (aplog-1) with anti-proliferative activity.

Kyoto University
Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.

University of Tsukuba
Nitrogen-containing heterocyclic compound and use thereof

Takeda Pharmaceutical